ClinicalTrials.Veeva
Menu

Find clinical trials for Triple Negative Breast Cancer in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Melanoma

Triple Negative Breast Cancer trials near San Antonio, TX, USA:

CD40 Agonist, Flt3 Ligand, and Chemotherapy in Triple Negative Breast Cancer

doxorubicin (PLD, Doxil) are safe and effective at controlling the cancer in patients with metastatic triple negative breast...

Enrolling
Metastatic Triple Negative Breast Cancer
Drug: CDX-1140
Drug: PLD Chemotherapy

Phase 1

The University of Texas System (UT)
The University of Texas System (UT)

San Antonio, Texas, United States and 5 other locations

of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...

Enrolling
Triple Negative Breast Neoplasms
Drug: Capivasertib
Drug: Datopotamab deruxtecan

Phase 1, Phase 2

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 46 other locations

This is a 3-arm study stratified by plasma ctDNA. Patients with residual TNBC disease after pre-operative therapy will be assigned to 1 of 3 Arms bas...

Enrolling
Breast Cancer
Triple Negative Breast Cancer
Drug: Inavolisib
Drug: Talazoparib

Phase 2

Bryan Schneider, MD

San Antonio, Texas, United States and 12 other locations

This trial studies ladiratuzumab vedotin (LV) with pembrolizumab in patients with triple-negative breast cancer. -...

Active, not recruiting
Triple Negative Breast Neoplasms
Drug: Pembrolizumab
Drug: ladiratuzumab vedotin

Phase 1, Phase 2

Seagen
Seagen

San Antonio, Texas, United States and 49 other locations

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

Phase 3

Gilead Sciences
Gilead Sciences

San Antonio, Texas, United States and 131 other locations

This study will assess the efficacy and safety of Niraparib in participants with either tumor mutation in the BRCA gene (tBRCAmut) HER2- breast...

Active, not recruiting
Neoplasms, Breast
Drug: Niraparib
Drug: Placebo

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

San Antonio, Texas, United States and 226 other locations

This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...

Enrolling
Hormone Receptor Positive Breast Cancer
Non-small Cell Lung Cancer
Drug: Steroid Containing Mouthwash
Other: Non-Steroid Containing Mouthwash

Phase 1

Daiichi Sankyo
Daiichi Sankyo

San Antonio, Texas, United States and 17 other locations

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...

Enrolling
Triple Negative Breast Cancer
PD-L1 Negative
Drug: Sacituzumab Govitecan-hziy
Drug: Paclitaxel

Phase 3

Gilead Sciences
Gilead Sciences

San Antonio, Texas, United States and 508 other locations

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...

Enrolling
Triple Negative Breast Cancer
PD-L1 Positive
Drug: Pembrolizumab
Drug: Paclitaxel

Phase 3

Gilead Sciences
Gilead Sciences

San Antonio, Texas, United States and 508 other locations

AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and...

Enrolling
Advanced Cancer
Pancreas Cancer
Drug: AGX101

Phase 1

Angiex, Inc.

San Antonio, Texas, United States and 1 other location

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems